D
R. Sheyi et al.
context, thereby paving the way for nucleophilic reactions
involving various peptides, antibodies and drugs.
CH, Ar), 7.40 (t, 2H, J ¼ 2.0 Hz, CH, Ar); 13C NMR (100 MHz,
CDCl3): 114.2 (C2,C6), 120.0 (C4), 125.9 (C3,C5), 128.9 (C-O),
170.0 (ClꢀC=N, triazine), 172.0 (O-C=N, triazine).
Experimental
Synthesis of 2-Chloro-4,6-disubstituted s-triazine (MST)
Materials and Methods
Nucleophile (0.27 mmol) was added to DST (0.27 mmol) in
EtOAc (1 mL), followed by addition of DIEA (47 mL,
0.27 mmol). The reaction was stirred at rt for 3 h. The progress of
the reaction was monitored by TLC (ethyl acetate/hexane as
mobile phase) until the complete consumption of the starting
material. The solution was concentrated to dryness and the
residue was dissolved in EtOAc and washed several times with
water to remove DIEA salts. The organic layer was collected,
dried over MgSO4, filtered and concentrated to afford pure
product, which was used for the next step without further
purification.
2,4,6-Trichloro-1,3,5-triazine (cyanuric chloride, TCT),
3-methylbutan-1-amine, 3-methylbutane-1-thiol, phenol and
diisopropylethylamine were purchased from Sigma-Aldrich
(Sigma-Aldrich, Germany). The solvents used were of analyti-
cal and HPLC reagent grade. Magnetic resonance spectra
(1H and 13C) were recorded on a Bruker 400 MHz instrument.
Chemical shift values were reported in d units (ppm) using TMS
as internal standard. Follow-up of the reactions and checks of
the purity of the compound was done by TLC on silica-gel-
protected aluminium sheets 60 F254 (Merck), and the spots were
detected by exposure to UV light at l ¼ 254 nm. Analytical
HPLC was performed on an Agilent 1100 system using a Phe-
nomenex C18 column (3 mm, 4.6 ꢁ 50 mm). Data were processed
using Chemstation software. Buffer A: 0.1 % TFA in H2O; and
buffer B: 0.1 % TFA in CH3CN were used in HPLC. Liquid
chromatography–mass spectrometry (LCMS) was performed
on Shimadzu 2020 UFLC using a YMC-Triart C18 (5 mm,
4.6 ꢁ 150 mm) column and data processing was carried out
using Laboratory Solution software. Buffer A: 0.1 % formic acid
in H2O; and buffer B: 0.1 % formic acid in CH3CN were used.
4-Chloro-N-isopentyl-6-(isopentylthio)-1,3,5-triazin-2-
amine (5)
Creamy oil; HPLC [30–95 % of CH3CN (0.1 % TFA/H2O
1
(0.1 % TFA) over 15 min] tR ¼ 10.7 min; H NMR (400 MHz,
CDCl3): 0.86 (m, 12H, 4CH3), 1.39 (m, 2H, 2CH), 1.51 (m, 4H,
2CH2), 3.00 (m, 2H, CH2), 3.36 (m, 2H, CH2), 5.28 (brs, -NH);
13C NMR (100 MHz, CDCl3): 21.3 (CH3), 21.5 (CH3), 26.5
(CH), 26.6 (CH), 27.0 (CH2-S), 27.2 (CH2), 37.4 (CH2), 38.1
(CH2-N), 161.7 (-N-C=N, triazine), 178.2 (ClꢀC=N, triazine),
179.2 (-S-C=N, triazine).
Synthesis of 4,6-Dichloro 2-Substituted s-Triazine (DST)
TCT (50 mg, 0.27 mmol) was dissolved in EtOAc (1 mL) and
cooled to 08C for 5 min. The nucleophile (0.27 mmol) was then
added to the above solution with stirring, followed by the
addition of DIEA (47 mL, 0.27 mmol). The reaction was stirred
at 08C (ꢀ208C in the case of phenol) for 30 min. The progress of
the reaction was monitored by TLC (EtOAc/hexane as mobile
phase) until no starting material was observed. The solution was
then concentrated to dryness, and the residue was dissolved in
EtOAc and washed several times with water to remove DIEA
salts. The organic layer was collected, dried over MgSO4,
filtered and concentrated to afford pure product, which was
used for the next step without further purification.
4-Chloro-N-isopentyl-6-phenoxy-1,3,5-triazin-2-amine (6)
Off-white solid; HPLC [30–95 % of CH3CN (0.1 % TFA/H2O
1
(0.1 % TFA) over 15 min] tR ¼ 9.1 min; H NMR (400 MHz,
CDCl3): 0.80 (d, 6H, J ¼ 6.6 Hz, 2CH3), 1.45 (m, 2H, CH2), 1.55
(m, 1H, CH), 3.27 (m, 2H, CH2), 7.05–7.33 (m, 5H, ArH); 13
C
NMR (100 MHz, CDCl3): 22.5 (CH3), 25.7 (CH), 38.6 (CH2),
39.1 (CH2-O), 122.1 (C2,C6), 124.9 (C4), 129.1 (C3,C5), 152.5
(Ph-O, phenoxy), 167.4 (ClꢀC=N, triazine), 175.4 (-O-C=N,
triazine), 179.7 (PhO-C=N, triazine).
2-Chloro-4-(isopentylthio)-6-phenoxy-1,3,5-triazine (7)
Yellowish semi-solid; HPLC [30–95 % of CH3CN (0.1 % TFA/
H2O (0.1 % TFA) over 15 min] tR ¼ 12.4 min; 1H NMR
(400 MHz, CDCl3): 0.90 (d, 6H, 2CH3), 1.50 (m, 2H, CH2), 1.60
(m, 1H, CH), 3.0 (m, 2H, CH2), 7.10–7.40 (m, 5H, ArH); 13C
NMR (100 MHz, CDCl3): 21.1 (CH3), 26.4 (CH), 27.7 (CH2),
36.9 (CH2-O), 120.5 (C2,C6), 124.9 (C4), 128.4 (C3,C5), 150.7
(Ph-O, phenoxy), 170.0 (ClꢀC=N, triazine), 172.6 (PhO-C=N,
triazine), 185.6 (-S-C=N, triazine).
4,6-Dichloro-N-isopentyl-1,3,5-triazin-2-amine (2)
Off-white semi-solid; HPLC [30–95 % of CH3CN (0.1 % TFA/
H2O (0.1 % TFA) over 15 min] tR ¼ 7.6 min; 1H NMR
(400 MHz, CDCl3): 0.90 (d, 2H, J ¼ 6.8 Hz, 2CH3), 1.40 (m, 2H,
CH2), 1.60 (m, 1H, CH), 3.4 (m, 2H, CH2-N), 5.7 (s, -NH); 13
C
NMR (100 MHz, CDCl3): 22.5 (2CH3), 25.7 (CH), 29.7 (CH2),
39.1 (CH2-N), 166.5 (N-C=N, triazine moiety), 166.8 (ClꢀC=N,
triazine moiety).
Synthesis of N-isopentyl-4-(isopentylthio)-6-phenoxy-1,3,5-
triazin-2-amine (8)
2,4-Dichloro-6-(isopentylthio)-1,3,5-triazine (3)
Isopentyl amine (0.27 mmol) was added to a stirred solution of
MST (0.27 mmol) in EtOAc (1 mL), followed by addition of
DIEA (0.27 mmol). The reaction mixture was heated to 358C for
8 h. The progress of the reaction was monitored by TLC (ethyl
acetate/hexane as mobile phase) until the complete consumption
of the starting material. Solvent was removed under vacuum,
and the residue was dissolved in EtOAc (5 mL). The organic
layer was washed several times with water to remove DIEA
salts. The organic layer was collected, dried over MgSO4, fil-
tered and concentrated to afford pure product.
Yellowish oil; HPLC [30–95 % of CH3CN (0.1 % TFA/H2O
1
(0.1 % TFA) over 15 min] tR ¼ 10.5 min; H NMR (400 MHz,
CDCl3): 0.90 (d, 6H, J ¼ 6.4 Hz, 2CH3), 1.55 (m, 2H, CH2), 1.65
(m, 1H, CH), 3.1 (m, 2H, CH2-S); 13C NMR (100 MHz, CDCl3):
21.2 (2CH3), 26.5 (CH), 28.3 (CH2-S), 36.2 (CH2), 169.0
(ClꢀC=N, triazine), 185.6 (S-C=N).
2,4-Dichloro-6-phenoxy-1,3,5-triazine (4)
Off-white solid; HPLC [30–95% of CH3CN (0.1% TFA/H2O
1
(0.1% TFA) over 15 min] tR ¼ 6.7 min; H NMR (400MHz,
Brownish semi-solid; HPLC [30–95% of CH3CN (0.1%
1
TFA/H2O (0.1% TFA) over 15 min] tR ¼ 13.3 min; H NMR
CDCl3): 7.10 (d, 2H, J ¼ 1.6 Hz, CH, Ar), 7.30 (t, 1H, J ¼ 1.6 Hz,